Literature DB >> 12829652

Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy.

Keith N Drummond1, Michael S Kramer, Samy Suissa, Claire Lévy-Marchal, Sophie Dell'Aniello, Alan Sinaiko, Michael Mauer.   

Abstract

Several studies have reported that the effect of type 1 diabetes disease duration on nephropathy may be greater during or after puberty than an equivalent number of years before puberty. The International Diabetic Nephropathy Study examined the effects of disease duration and age at onset on glomerular morphometry obtained from kidney biopsy in 243 young type 1 diabetic subjects with albumin excretion rates <100 micro g/min: 184 with prepubertal onset, 35 with pubertal onset, and 24 with postpuberty onset. Outcomes included the volume fraction of the glomerulus occupied by the mesangium [Vv(Mes/glom)], glomerular basement membrane (GBM) width, and the surface density of peripheral glomerular capillary basement membrane per glomerulus Sv(PGBM/glom). Vv(Mes/glom) progressed slowly in the first 14 or 15 years after disease onset but more rapidly thereafter. GBM width increased, while Sv(PGBM/glom) decreased with increasing disease duration. No statistically significant differences in the effect of duration were observed among the three age-at-onset subgroups, even with multivariate adjustment for sex, center, baseline HbA(1c) concentration, diastolic blood pressure, height, and BMI. Our results may explain the conflicting results of previous studies regarding the effects of pre-versus postpuberty disease duration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829652     DOI: 10.2337/diabetes.52.7.1818

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

1.  Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor.

Authors:  P Y Chuang; Q Yu; W Fang; J Uribarri; J C He
Journal:  Kidney Int       Date:  2007-08-01       Impact factor: 10.612

2.  Renal complications of childhood type 1 diabetes.

Authors:  Jean-Claude Carel; Claire Levy-Marchal
Journal:  BMJ       Date:  2008-03-18

3.  Podocyte structural parameters do not predict progression to diabetic nephropathy in normoalbuminuric type 1 diabetic patients.

Authors:  Tasma Harindhanavudhi; Alicia Parks; Michael Mauer; M Luiza Caramori
Journal:  Am J Nephrol       Date:  2015-05-22       Impact factor: 3.754

4.  Sex-related differences in the long-term risk of microvascular complications by age at onset of type 1 diabetes.

Authors:  V Harjutsalo; C Maric; C Forsblom; L Thorn; J Wadén; P H Groop
Journal:  Diabetologia       Date:  2011-04-21       Impact factor: 10.122

Review 5.  The natural progression of kidney injury in young type 1 diabetic patients.

Authors:  Julia M Steinke
Journal:  Curr Diab Rep       Date:  2009-12       Impact factor: 4.810

Review 6.  Morphologic features of declining renal function in type 1 diabetes.

Authors:  Behzad Najafian; Michael Mauer
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

7.  Renal lesions predict progression of diabetic nephropathy in type 1 diabetes.

Authors:  M Luiza Caramori; Alicia Parks; Michael Mauer
Journal:  J Am Soc Nephrol       Date:  2013-05-16       Impact factor: 10.121

8.  Follow-up of kidney biopsies in normoalbuminuric patients with type 1 diabetes.

Authors:  Nina Elisabeth Staffansdotter Sohlman Perrin; Torun Birgitta Torbjörnsdotter; Georg Alexander Jaremko; Ulla Birgitta Berg
Journal:  Pediatr Nephrol       Date:  2004-06-23       Impact factor: 3.714

Review 9.  Diabetic nephropathy in children and adolescents.

Authors:  Radovan Bogdanović
Journal:  Pediatr Nephrol       Date:  2007-10-17       Impact factor: 3.714

10.  Age at menarche and the risk of diabetic microvascular complications in patients with type 1 diabetes.

Authors:  Valma Harjutsalo; Christine Maric-Bilkan; Carol Forsblom; Per-Henrik Groop
Journal:  Diabetologia       Date:  2015-11-25       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.